Early Stage Medtech Crowdfunding Featured at OneMedForum

January 2, 2014 @ 10:39 am By JD Alois

The 7th Annual OneMedForum San Francisco finance conference for emerging companies is scheduled to take place this January 13-14, 2014. A portion of the conference will cover medical technology crowdfunding. A panel has been set featuring early entrants in the emerging area of crowdfunding, who will offer their outlook on this new approach to funding.

Moderated by Joe B. Johnson, a Partner and Assurance Business Line Leader with BDO USA’s Orange County office and a member of the firm’s Life Sciences practice, the panel will feature:

Andrew Farquharson, VentureHealth
Scott Jordan, HealthiosXchange
Sean Schantzen, Healthfundr
Greg Simon, Poliwogg

Joe Johnson states that,

“Equity crowdfunding for medical technology companies holds the promise of tapping vast amounts of capital to fund innovation. Our panel will offer perspective about how this may evolve in 2014.”

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Nov 4, 2026 vs Jan 1, 2025 - Nov 4, 2025

Number of Filings134Prior 129 +3.9%

Target Raise, Total$3.45BPrior $3.59B -3.8%

	This YTD	Year prior	Change
Filings	134	129	+3.9%
Target raise	$3.45B	$3.59B	-3.8%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes

Article Rating

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments

Newest

Oldest Most Voted